• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

(old research) Severe ME/CFS in Adults - A report from the CHROME Database

RogerBlack

Senior Member
Messages
902
I found this interesting, as I had not heard of the CHROME dataset, and wonder if it is still worked on. This was a self-selected survey.
http://iacfsme.org/ME-CFS-Primer-Education/Bulletins/2009/Severe-ME-CFS-in-Adults-A-report-from-the-CH-(1).aspx

A followup attempt 20 years on could be very interesting, though of course problematic. A substantial number of patients will have died of natural causes, which could in itself be interesting.

BACKGROUND: Case History Research on ME (CHROME) was established in 1994 to undertake research on severely affected patients. Since 1995 CHROME has collected data on volunteers with severe ME/CFS. All are medically diagnosed, conform to Fukuda criteria, are or were house-bound, and ill for at least two years. Participants complete initial and annual follow-up questionnaires, and report their condition at onset of illness, a year previously, on recruitment, and annually thereafter.

METHOD: We report symptom severity and ability to undertake activities of daily living in 324 participants recruited between 1995 and 1998, their evolution through time, and, for later onset (age 17+) subjects, changes occurring between recruitment and the latest questionnaire. Significance was assessed using the McNemar test or its binomial equivalent. RESULTS: For most features, subjects deteriorated between onset and recruitment, with subsequent improvement, often slow and uneven, among later onset cases. Complete recovery was unusual. There were marked individual variations, and many subjects remained severely incapacitated or deteriorated. All features examined were more prevalent and severe in patients with a younger age of onset. Age at onset was bimodal, with peaks at 11-20 and 31-40. Most subjects, at recruitment, had been ill for 2-10 years. The proportion of early onset cases rose significantly in the mid-1980s.

CONCLUSIONS: Caution is necessary in interpreting the results, given problems of self- selection, recall bias, and subjective interpretations of symptom ratings. It is unclear whether the reported trends are inevitable features of ME/CFS, or perhaps due to poor management at the outset.

Final%20CHROME%20Report%20Figure%202.jpg


Dr Sneddon (if it is the same person) seems to have moved on to directing clinical research for a university/NHS project in Sheffield, and the other author last published on CFS in 2014. http://me-pedia.org/wiki/Derek_Pheby
 
Last edited: